Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (6)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Gamzu, R.
Right arrow Articles by Bar-Am, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gamzu, R.
Right arrow Articles by Bar-Am, A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 17, No. 10, 2585-2587, October 2002
© 2002 European Society of Human Reproduction and Embryology

The ultrasonographic appearance of tubal pregnancy in patients treated with methotrexate

Ronni Gamzu1, Benny Almog, Yishai Levin, David Pauzner, Joseph B. Lessing, Ariel Jaffa and Amiram Bar-Am

Lis Maternity Hospital, Tel Aviv Sourasky Medical Center, 6 Weizmann St., Tel Aviv, 64239, affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

BACKGROUND: The aim of the present study was to evaluate the effect of methotrexate (MTX) treatment on the ultrasonographic appearance of extrauterine pregnancy (EUP) and, particularly, to test the hypothesis that the ultrasonographic appearance is not predictive of treatment success. METHODS: A prospective cohort study. The study group included 56 women with tubal EUP who received a single-dose protocol of MTX. EUP was diagnosed whenever an intrauterine gestational sac was not identified by transvaginal ultrasonography (TVUS), accompanied by an abnormal rise or plateau in hCG concentration. Serial TVUS was performed weekly until hCG normalization or the size of the ectopic mass declined to 1 cm2. RESULTS: Ectopic tubal mass was identified on TVUS in 45 (80%) women with a mean size of 4 ± 0.5 cm2. Following the first week of MTX injection, the mean size of the ectopic mass significantly increased to 6 ± 0.8 cm2 (P = 0.02). The initial size of the ectopic mass was not related to the success of the treatment nor to serum hCG levels. Ultrasonographic resolution of the ectopic mass was documented in 27 women following a mean of 42 ± 2.4 days (range 7–63 days). CONCLUSIONS: The initial size of a tubal pregnancy is not related to the success of MTX treatment. MTX treatment in tubal pregnancy is followed by an initial increase in the size of the ectopic mass. Accordingly, such enlargement of the ectopic mass should not be considered as a higher risk for failure of treatment.

Key words: extra-uterine pregnancy/methotrexate/transvaginal ultrasonography

1 To whom correspondence should be addressed at: Institute for the Study of Fertility, Lis Maternity Hospital, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel 64239. E-mail: ronn{at}post.tau.ac.il


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J Ultrasound MedHome page
M. J. Song, M. H. Moon, J.-A. Kim, and T. J. Kim
Serial Transvaginal Sonographic Findings of Cervical Ectopic Pregnancy Treated With High-Dose Methotrexate
J. Ultrasound Med., January 1, 2009; 28(1): 55 - 61.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.